CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −10,211 | $20.99 | $214K | 733,158 |
| 2024-05-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −11,478 | $20.99 | $241K | 721,680 |
| 2024-05-13 | WYSZOMIERSKI JACK L Director | Option exercise 10b5-1 | +11,686 | $19.57 | $229K | 349,871 |
| 2024-05-13 | WYSZOMIERSKI JACK L Director | Sale 10b5-1 | −10,923 | $21.37 | $233K | 338,948 |
| 2024-05-13 | WYSZOMIERSKI JACK L Director | Option exercise · Option (right to buy) 10b5-1 | −11,686 | 0 | ||
| 2024-03-21 | Garber Alan M Director | Option exercise 10b5-1 | +23,491 | $19.57 | $460K | 54,908 |
| 2024-03-21 | Garber Alan M Director | Sale 10b5-1 | −19,205 | $24.01 | $461K | 35,703 |
| 2024-03-21 | Garber Alan M Director | Option exercise · Option (right to buy) 10b5-1 | −23,491 | 0 | ||
| 2024-02-23 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Grant or award | +82,121 | 322,121 | ||
| 2024-02-23 | Aftab Dana CSO/EVP Disc & Trans Research | Grant or award | +63,350 | 542,381 | ||
| 2024-02-23 | MORRISSEY MICHAEL President and CEO | Grant or award | +241,670 | 1,038,327 | ||
| 2024-02-23 | Senner Christopher J. EVP and CFO | Grant or award | +82,121 | 751,990 | ||
| 2024-02-23 | Hessekiel Jeffrey EVP, General Counsel & Sec | Grant or award | +63,350 | 655,052 | ||
| 2024-02-23 | Haley Patrick J. EVP, Commercial | Grant or award | +63,350 | 431,886 | ||
| 2024-02-23 | Haley Patrick J. EVP, Commercial | Sale | −47,020 | $21.45 | $1.0M | 384,866 |
| 2024-02-21 | JOHNSON DAVID EDWARD Director | Purchase | +190,000 | $20.70 | $3.9M | 1,100,730 |
| 2024-02-15 | Aftab Dana CSO/EVP Disc & Trans Research | Shares withheld for taxes | −10,630 | $20.39 | $217K | 479,031 |
| 2024-01-11 | MORRISSEY MICHAEL President and CEO | Grant or award | +250,374 | 860,374 | ||
| 2024-01-11 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −63,717 | $22.86 | $1.5M | 796,657 |
| 2024-01-11 | Senner Christopher J. EVP and CFO | Grant or award | +80,186 | 691,731 |
Page 16 of 20 · 381 trades